Read More 1 minute read Analyst Color Analyst Ratings News Price Target Reiteration Tech IPG Photonics Likely To Gain From China’s Recovery, Medical And EV Applications Analyst Says Post Q4 By Anusuya Lahiri February 15, 1:22 PM Benchmark analyst Mark Miller maintained IPG Photonics Corp (NASDAQ:IPGP) with a Buy and raised the price target from $130 to $140. IPG’s… IPGP
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Geovax Labs, Maintains $8 Price Target By Benzinga Newsdesk February 15, 12:25 PM HC Wainwright & Co. analyst Vernon Bernardino reiterates Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $8 price target. GOVX
Read More 1 minute read Analyst Color Analyst Ratings Downgrades News Price Target Reiteration Tech Akamai Leaves Analysts Concerned Following Aggressive Shift To Computing, A Field Dominated By AWS, Azure, GCP By Anusuya Lahiri February 15, 12:11 PM RBC Capital analyst Rishi Jaluria downgraded Akamai Technologies Inc (NASDAQ:AKAM) from Outperform to Sector Perform and reduced the price target from $100… AKAM
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Lowers Price Target to $61 By Benzinga Newsdesk February 15, 12:02 PM HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and lowers the price target from $69 to $61. MIRM
Read More 1 minute read Analyst Ratings News Price Target Reiteration Barrington Research Reiterates Outperform on Alithya Group, Maintains C$3.5 Price Target By Benzinga Newsdesk February 15, 10:18 AM Barrington Research analyst Vincent Colicchio reiterates Alithya Group (TSX:ALYA) with a Outperform and maintains C$3.5 price target. ALYA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Outperform on MasTec, Maintains $122 Price Target By Benzinga Newsdesk February 15, 9:36 AM Credit Suisse analyst Jamie Cook reiterates MasTec (NYSE:MTZ) with a Outperform and maintains $122 price target. MTZ
Read More 1 minute read Analyst Ratings News Price Target Reiteration Benchmark Reiterates Buy on Quipt Home Medical, Maintains $10 Price Target By Benzinga Newsdesk February 15, 8:28 AM Benchmark analyst Bill Sutherland reiterates Quipt Home Medical (NASDAQ:QIPT) with a Buy and maintains $10 price target. QIPT
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Upexi, Maintains $7 Price Target By Benzinga Newsdesk February 15, 8:03 AM EF Hutton analyst Michael Albanese reiterates Upexi (NASDAQ:UPXI) with a Buy and maintains $7 price target. UPXI
Read More 1 minute read Analyst Ratings News Price Target Reiteration Jefferies Reiterates Buy on Danaos, Maintains $80 Price Target By Benzinga Newsdesk February 15, 7:43 AM Jefferies analyst Omar Nokta reiterates Danaos (NYSE:DAC) with a Buy and maintains $80 price target. DAC
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Bicycle Therapeutics, Maintains $55 Price Target By Benzinga Newsdesk February 15, 7:22 AM EF Hutton analyst Tony Butler reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $55 price target. BCYC